FDA再次拒绝Galderma的保妥适竞争对手Relfydess,导致股价暴跌
Tap title to read story
0:00 / 1:30
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story